Experienced in Antisynthetase Syndrome

Yasuhiko Yamano

Seto, JP 
Experienced in Antisynthetase Syndrome
Seto, JP 
OverviewLocationsClinical Research

Overview

Yasuhiko Yamano practices in Seto, Japan. Yamano is rated as an Experienced expert by MediFind in the treatment of Antisynthetase Syndrome. Their top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, and Idiopathic Pulmonary Fibrosis.

Their clinical research consists of co-authoring 76 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Antisynthetase Syndrome.

Locations

Seto, Japan
Other Locations
Okazaki, Japan
Japan
St. Luke's International Hospital, 9-1, Akashi Cho, Chuo City, Tokyo, 1048560, Japan
St. Luke's International Hospital, 9-1 Akashi Cho, Chuo, 1048560, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Single Arm, Multi-center Study to Assess the Long-term Real-world Safety and Effectiveness of Nucala in EGPA Patients Who Have Already Used Nucala for at Least 96 Weeks in Japan
A Single Arm, Multi-center Study to Assess the Long-term Real-world Safety and Effectiveness of Nucala in EGPA Patients Who Have Already Used Nucala for at Least 96 Weeks in Japan
Enrollment Status: Completed
Publish Date: September 19, 2024

76 Total Publications

Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA.
Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA.
Journal: RMD open
Published: March 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yamano's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile